Pancreatic Cyst Clinical Trial
Official title:
A Pilot Study of Chemoprevention With Tamoxifen in Patients With Pre-Invasive Pancreas Mucinous Cystic Neoplasms Who Will Not Undergo Immediate Resection
This is an open-label pilot study of tamoxifen as chemoprevention in patients with pancreatic mucinous cystic neoplasms (MCN) who will not undergo immediate resection. Up to 15 participants will be enrolled and take tamoxifen 20mg by mouth daily for up to 24 weeks.
This is an open-label pilot study of tamoxifen as chemoprevention in patients with pancreatic mucinous cystic neoplasms (MCN) who will not undergo immediate resection. Up to 15 participants will be enrolled and take tamoxifen 20mg by mouth daily for up to 24 weeks. The primary endpoints are feasibility of tamoxifen as chemoprevention in participants with pancreatic MCN and objective response rate as assessed by magnetic resonance imaging (MRI). This study is intended to inform the design of a subsequent trial formally powered to detect the benefit of tamoxifen in treating pancreatic MCN. The clinical features of pancreatic MCN support the influence of sex hormones in the pathogenesis of the disease. Anti-hormonal therapy may therefore constitute an effective approach to treatment of MCN and chemoprevention of pancreatic adenocarcinoma. Preliminary analyses from preclinical studies suggest that tamoxifen inhibits proliferation and apoptosis in MCN epithelial cells and fibroblasts. Investigators hypothesize that in humans, treatment with tamoxifen will lead to cyst regression or stabilization and may spare or delay the need for resection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05572788 -
Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts
|
N/A | |
| Completed |
NCT01770405 -
Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
|
N/A | |
| Completed |
NCT01643460 -
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
|
N/A | |
| Recruiting |
NCT03260842 -
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
|
||
| Recruiting |
NCT04291651 -
UCSF PANC Cyst Registry
|
||
| Recruiting |
NCT05692596 -
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
|
||
| Recruiting |
NCT03334708 -
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
|
||
| Recruiting |
NCT04140435 -
EUS-guided Through-the-needle Microforceps Biopsy Outcomes
|
||
| Terminated |
NCT00550108 -
Management of Incidentally Discovered Pancreatic Cysts
|
Phase 3 | |
| Recruiting |
NCT03492151 -
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
|
||
| Completed |
NCT03169842 -
Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts
|
N/A | |
| Recruiting |
NCT04404101 -
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
|
N/A | |
| Recruiting |
NCT06305728 -
A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
|
||
| Recruiting |
NCT06340620 -
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
|
N/A | |
| Recruiting |
NCT02343692 -
A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas
|
N/A | |
| Recruiting |
NCT02775461 -
Pancreas Registry and High Risk Registry
|
||
| Active, not recruiting |
NCT01563133 -
Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
|
N/A | |
| Completed |
NCT00222898 -
Cancer Detection in Pancreatic Cysts
|
N/A | |
| Not yet recruiting |
NCT06276764 -
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
|
||
| Completed |
NCT03740360 -
Contrast Enhanced Ultrasound and Molecular Analysis in the Diagnosis of Pancreatic Cyst
|